课题基金 / 基金详情

SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES

SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES
寻找新型 B 细胞过度活跃基因
批准号:
6235685
负责人:
SYAMAL K DATTA
金额:
$15.69万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-01 至 1997-11-30

项目摘要

项目成果

SYAMAL K DATTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long-term goal is to identify the genes and their products that determine hyperactivity of B cells, particularly B-1 (DC5-lineage) B cells. New Zealand Black (NZB) mice, that have a life-long hyperactivity ob B-1 cells, will be studied. NZB mice not only develop autoimmune disease but also a high incidence of malignant lymphomas of B-1 B cells that are very similar to human CLL and the B cell lymphomas developing the AIDS patients. In addition B-1 B cells are hyperactive in the inflamed joints of rheumatoid arthritis (RA) patients where they play a major role in antigen presentation and activation of inflammatory cells. We have preliminary evidence showing that the hyperactive B cells of NZB mice differentially express several genes that are not expressed in normal B cells. In this development and feasibility study, we would like to confirm the identity of these B cell hyperactivity genes. Eventually we aim to clone the full length cDNA for these differentially expressed genes, sequence them, study their genomic organization and define their function. This search for B cell hyperactivity genes may reveal novel genes or new function for known genes. Besides its relevance to RA and malignant B cell lymphomas as stated above, this project could enhance our understanding of the basic mechanisms of B cell differentiation, signal transduction, tolerance and apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
IMMUNE MECHANISMS OF ANTICD40L TRIAL IN SLE
SEARCH FOR NOVEL B CELL HYPERACTIVITY GENES
海外基金